Skip to main content

Eazyplex BloodScreen GN

The eazyplex® BloodScreen GN test system is a qualitive in vitro diagnositic medical device for the detection, and reliable indentification of Gram-negative pathogens from positive flagged blood culture vials. 

 

The following panels are available: 

  • eazyplex®BloodScreen GN, for the determination of E. coli, K. pneumoniae, K. oxytoca, P. aeruginosa, CTX-M-1 group, CTX-M-9 group, P. mirabilis. 
  • eazyplex®BloodScreen GP, for the determination of VanA, VanB, Enterococcus faecalis, Enterococcus spec., S. pneuomiae, Streptococcus spec. 

The test can be performed at any time by qualified professional staff in a medical laboratory in order to:

  • Aid in the diagnosis (providing additional information to assist in the determination or verification of a patient's clinical status, test is not the sole determinant) of all kinds of patients via testing positive blood culture vials. 

In addition to 5 different Gram-negative pathogens, eazyplex® BloodScreen GN also detects the two most frequent gene groups that genetically determine an ESBL phenotype (CTX-M-1 and CTX-M-9 group). 

 

The most common parameters are available with the eazyplex® BloodScreen Panels for the Gram-positive and Gram-negative spectrum. 

The examination is carried out directly from the positive blood culture without DNA extraction, 

  • Hands-on-time of approximately 3 minutes. 
  • First signals in less than 10 minutes 
  • Complete test run finishing within as little as 20 minutes 
  • Results can be exported as PDF, CSV and adhesive label. 

All signals are displayed in real-time during the amplification process!

 

Protective mechanisms to prevent the use of false results: 

  • Performance of "Inhibition control" with each sample, preventing the use of false negative tests due to the inhibition of the amplification reaction and simultaneously serves as reagent control. 
  • The test result is only displayed if the inhibition control is valid. 
  • A test strip can be processed as a negative/ contamination control when required. Achieved via the testing of RALF without the addition of sample material. In this case only the inhibition control is allowed to create a positive signal. 

Specifications

  • Quantity: 24
  • Product Code: AM-E7676

Related Products

  • Genie II MK2

    Genie II MK2

    The Genie® family, with the Genie® II MK2 and the Genie® HT. A modern and customer-friendly diagnostic device series.

    The compact Genie® II is a light and robust device for quick individual tests 24/7. The device has two heating blocks, which can be controlled independently of one another and thus offer maximum flexibility.

  • Eazyplex BloodScreen GP

    Eazyplex BloodScreen GP

    The eazyplex®BloodScreen GP system, for qualitive in vitro diagnostics of reliable identification and detection of Gram-positive pathogens from positive flagged blood culture vials. 

     

    The following panels are available: 

    • eazyplex®BloodScreen GN, for the determination of E. coli, K. pneumoniae, K. oxytoca, P. aeruginosa, CTX-M-1 group, CTX-M-9 group, P. mirabilis. 
    • eazyplex®BloodScreen GP, for the determination of VanA, VanB, Enterococcus faecalis, Enterococcus spec., S. pneuomiae, Streptococcus spec. 

    The test can be performed at any time by qualified professional staff in a medical laboratory in order to:

    • Aid in the diagnosis (providing additional information to assist in the determination or verification of a patient's clinical status, test is not the sole determinant) of all kinds of patients via testing positive blood culture vials.